IQVIA Holdings SG&A Expenses 2011-2025 | IQV
IQVIA Holdings annual/quarterly sg&a expenses history and growth rate from 2011 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- IQVIA Holdings sg&a expenses for the quarter ending March 31, 2025 were $508M, a 0% increase year-over-year.
- IQVIA Holdings sg&a expenses for the twelve months ending March 31, 2025 were $1.992B, a 2.73% decline year-over-year.
- IQVIA Holdings annual sg&a expenses for 2024 were $1.992B, a 2.97% decline from 2023.
- IQVIA Holdings annual sg&a expenses for 2023 were $2.053B, a 0.87% decline from 2022.
- IQVIA Holdings annual sg&a expenses for 2022 were $2.071B, a 5.45% increase from 2021.
| IQVIA Holdings Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $1,992 |
| 2023 | $2,053 |
| 2022 | $2,071 |
| 2021 | $1,964 |
| 2020 | $1,789 |
| 2019 | $1,734 |
| 2018 | $1,716 |
| 2017 | $1,622 |
| 2016 | $1,016 |
| 2015 | $815 |
| 2014 | $781 |
| 2013 | $861 |
| 2012 | $818 |
| 2011 | $762 |
| 2010 | $698 |
| IQVIA Holdings Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $508 |
| 2024-12-31 | $453 |
| 2024-09-30 | $522 |
| 2024-06-30 | $509 |
| 2024-03-31 | $508 |
| 2023-12-31 | $556 |
| 2023-09-30 | $502 |
| 2023-06-30 | $482 |
| 2023-03-31 | $513 |
| 2022-12-31 | $583 |
| 2022-09-30 | $517 |
| 2022-06-30 | $483 |
| 2022-03-31 | $488 |
| 2021-12-31 | $542 |
| 2021-09-30 | $498 |
| 2021-06-30 | $482 |
| 2021-03-31 | $442 |
| 2020-12-31 | $491 |
| 2020-09-30 | $460 |
| 2020-06-30 | $431 |
| 2020-03-31 | $407 |
| 2019-12-31 | $484 |
| 2019-09-30 | $395 |
| 2019-06-30 | $436 |
| 2019-03-31 | $419 |
| 2018-12-31 | $443 |
| 2018-09-30 | $429 |
| 2018-06-30 | $424 |
| 2018-03-31 | $420 |
| 2017-12-31 | $469 |
| 2017-09-30 | $394 |
| 2017-06-30 | $378 |
| 2017-03-31 | $381 |
| 2016-12-31 | $393 |
| 2016-09-30 | $207 |
| 2016-06-30 | $216 |
| 2016-03-31 | $200 |
| 2015-12-31 | $138 |
| 2015-09-30 | $231 |
| 2015-06-30 | $226 |
| 2015-03-31 | $220 |
| 2014-12-31 | $124 |
| 2014-09-30 | $219 |
| 2014-06-30 | $219 |
| 2014-03-31 | $219 |
| 2013-12-31 | $233 |
| 2013-09-30 | $200 |
| 2013-06-30 | $229 |
| 2013-03-31 | $199 |
| 2012-12-31 | $223 |
| 2012-09-30 | $193 |
| 2012-06-30 | $204 |
| 2012-03-31 | $206 |
| 2011-12-31 | |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $24.064B | $15.405B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $198.309B | 86.86 |
| Thermo Fisher Scientific (TMO) | United States | $149.665B | 18.10 |
| Edwards Lifesciences (EW) | United States | $45.813B | 30.04 |
| Alcon (ALC) | Switzerland | $42.010B | 28.39 |
| IDEXX Laboratories (IDXX) | United States | $41.401B | 47.58 |
| DexCom (DXCM) | United States | $33.529B | 51.82 |
| STERIS (STE) | Ireland | $23.814B | 26.23 |
| Mettler-Toledo (MTD) | United States | $23.716B | 28.20 |
| Waters (WAT) | United States | $20.452B | 28.86 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.615B | 0.00 |
| Hologic (HOLX) | United States | $13.819B | 15.02 |
| Sysmex ADR (SSMXY) | Japan | $10.581B | 30.02 |
| Penumbra (PEN) | United States | $9.920B | 77.86 |
| Masimo (MASI) | United States | $8.948B | 33.01 |
| Globus Medical (GMED) | United States | $7.982B | 19.02 |
| Glaukos (GKOS) | United States | $5.416B | 0.00 |
| Teleflex (TFX) | United States | $5.288B | 8.73 |
| TransMedics (TMDX) | United States | $4.192B | 91.13 |
| Integer Holdings (ITGR) | United States | $4.106B | 21.52 |
| PROCEPT BioRobotics (PRCT) | United States | $3.206B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.367B | 14.09 |
| Veracyte (VCYT) | United States | $2.094B | 29.39 |
| Nihon Kohden (NHNKY) | Japan | $2.022B | 23.19 |
| Elekta AB (EKTAY) | Sweden | $1.985B | 17.84 |
| Alphatec Holdings (ATEC) | United States | $1.798B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.226B | 114.84 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $1.094B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.957B | 5.09 |
| Beta Bionics (BBNX) | United States | $0.810B | 0.00 |
| SiBone (SIBN) | United States | $0.804B | 0.00 |
| IRadimed (IRMD) | United States | $0.735B | 37.28 |
| RxSight (RXST) | United States | $0.631B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.568B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.559B | 8.69 |
| Mesa Laboratories (MLAB) | United States | $0.534B | 12.53 |
| AxoGen (AXGN) | United States | $0.500B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.485B | 0.00 |
| NeuroPace (NPCE) | United States | $0.428B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.425B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.397B | 10.56 |
| AngioDynamics (ANGO) | United States | $0.394B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.361B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.330B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.296B | 0.00 |
| Neuronetics (STIM) | United States | $0.251B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.93 |
| 908 Devices (MASS) | United States | $0.213B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.206B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.201B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.192B | 0.00 |
| Inogen (INGN) | United States | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| CVRx (CVRX) | United States | $0.169B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.167B | 0.00 |
| Accuray (ARAY) | United States | $0.160B | 0.00 |
| LENSAR (LNSR) | United States | $0.159B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.151B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.20 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| Hyperfine (HYPR) | United States | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.46 |